PACS Group, Inc. (PACS)

NYSE: PACS · USD

$49.1

+1.24 (+2.6%)· Recorded snapshot

Market cap	7.8B
Revenue (ttm)	5.6B
Net income (ttm)	269.2M
EPS (ttm)	$1.71
Shares out	158.3M
P/E (trailing)	28.7x
P/E (forward)	19.4x
Volume	578,716
Beta	-0.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.6B
Net income (ttm): 269.2M
EPS (ttm): $1.71
P/E (trailing): 28.7x
P/E (forward): 19.4x
Market cap: 7.8B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.4

P25 n/aP50 n/aP75 n/a

Trailing P/E28.7

P25 n/aP50 n/aP75 n/a

ROE27.9

P25 n/aP50 n/aP75 n/a

ROIC6.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PACS indicators

Market & fundamental data

Available fields

245

Groups with data

Currency

USD

Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0002001184
Company name	PACS Group, Inc.
Country	United States
Country code	US
CUSIP number	69380Q107
Earnings date	2026-11-03
Earnings time	amc
Employees	47,455
Employees change	1,775
Employees growth	3.89%
Enterprise value	$11B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
In index	RUSSELL2000
Industry	Medical Care Facilities
IPO date	2024-04-11
Is primary listing	Yes
Is SPAC	No
ISIN number	US69380Q1076
Last 10-K release date	2026-02-27
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$7.8B
Market cap category	Mid-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$49.09
Price currency	USD
Sector	Healthcare
SIC code	8051
Stock price date	2026-10-28
Symbol	PACS
U.S. state	Utah
Website	https://pacs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	21.45x
Average P/E ratio (3Y)	41.48x
Earnings yield	3.48%
EV/Earnings	41.07x
EV/EBIT	26.94x
EV/EBITDA	23.11x
EV/FCF	24.25x
EV/Sales	1.99x
FCF / EV yield	4.12%
FCF yield	5.83%
Forward EV/Sales	1.76x
Forward P/E	19.36x
Forward P/S	1.25x
Graham number	16.42739
Graham upside	-66.71%
Industry forward P/E	14.81x
Industry P/E	18.21x
Lynch fair value	$42.76
Lynch upside	-13.36%
P/(FCF - SBC) ratio	20.49x
P/(OCF - SBC) ratio	15.67x
P/B ratio	6.82x
P/E ratio	28.7x
P/FCF ratio	17.14x
P/OCF ratio	13.63x
P/S ratio	1.41x
PEG ratio	1.26x
Price / tangible book value	7.5x
Price/EBITDA ratio	16.34x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	7.39%
EBITDA margin	8.62%
Effective tax rate	29.67%
FCF margin	8.21%
Gross margin	17.32%
Operating margin	7.39%
Pretax margin	6.89%
Profit margin	4.85%
Profit per employee	$5,672
Profitable quarters	8
Profitable years	5
Revenue per employee	$116,975
ROA	4.6%
ROCE	8.92%
ROE	27.92%
ROIC	6.67%
SBC / revenue	1.34%
Tax / revenue	2.05%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	107.44%
EPS growth (Q)	51.61%
EPS growth (QoQ)	-6%
EPS growth 3Y	66.21%
EPS growth quarters	5
EPS growth years	1
FCF growth	13.95%
FCF growth (Q)	220.51%
FCF growth (QoQ)	-49.19%
Gross profit growth	44.43%
Gross profit growth (Q)	24.8%
Gross profit growth 3Y	69.7%
Net income growth	103.52%
Net income growth (Q)	49.85%
Net income growth (QoQ)	-5.36%
Net income growth 3Y	77.73%
Net income growth quarters	5
Net income growth years	1
OCF growth	20.27%
OCF growth (Q)	157.75%
OCF growth (QoQ)	-42.66%
OCF growth 3Y	115.1%
Operating income growth	83.52%
Operating income growth (Q)	35.82%
Operating income growth 3Y	70.11%
Revenue growth	15.15%
Revenue growth (Q)	9.07%
Revenue growth (QoQ)	0.53%
Revenue growth 3Y	68.2%
Revenue growth quarters	10
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-117.5M
Depreciation and amortization	$68M
EBIT	$410.3M
EBITDA	$478.3M
EPS	$1.71
FCF per share	$2.88
Financing cash flow	$-196.1M
Free cash flow	$455.8M
Free cash flow minus SBC	$381.3M
Gross profit	$961.2M
Income taxes	$113.5M
Investing cash flow	$-497.9M
Net borrowing	$-155.2M
Net cash flow	$-120.7M
Net income	$269.2M
Operating cash flow minus SBC	$498.8M
Operating income	$410.3M
Revenue	$5.6B
Stock-based compensation	$74.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.86
Book value per share	$7.01
Debt / EBITDA	3.77
Debt / equity	3.05
Debt / FCF	7.47
Goodwill	$61.8M
Interest coverage	13.88
Long-term assets	$4.7B
Long-term liabilities	$3.5B
Net cash (debt)	$-3.2B
Net cash / market cap	-41.47%
Net debt / EBITDA	6.77
Net debt / equity	2.91
Net debt / FCF	7.11
Piotroski F-Score	6
Property, plant and equipment	$4.3B
Shareholders' equity	$1.1B
Tangible book value	$1B
Tangible book value per share	$6.58
Total assets	$5.7B
Total cash	$164.5M
Total debt	$3.4B
Total liabilities	$4.5B
WACC	2.84%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.99
Current assets	$962.4M
Current liabilities	$1.1B
Current ratio	0.91
Net working capital	$-64.2M
Quick ratio	0.84
Working capital	$-92.7M
Working capital turnover	-60.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.85%
Dividend yield	0%
Shareholder yield	2.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$40.63
1D price change	2.59%
1M price change	18.86%
1M total return	18.86%
1W price change	4.98%
1W total return	4.98%
1Y price change	289.6%
1Y return CAGR	289.97%
1Y total return	289.6%
20-day SMA	$45.46
200-day SMA	$39.63
3M price change	4.27%
3M total return	4.27%
50-day SMA	$43.99
50-day SMA vs 200-day SMA	50over200
52-week high	$50.38
52-week high date	2026-10-28
52-week low	$10.31
52-week low date	2025-11-14
6M price change	39.18%
6M total return	39.18%
All-time high	$50.38
All-time high date	2026-10-28
All-time low	$7.50
All-time low date	2025-09-09
Average true range (ATR)	$1.83
Average volume	812K
Beta (1Y)	-1.71
Beta (2Y)	-0.29
Beta (5Y)	-0.08
Change from 52-week high	-2.56%
Change from 52-week low	376.14%
Change from all-time high	-2.56%
Change from all-time low	554.53%
Change from open	-0.73%
Day's gap	3.34%
Dollar volume	$28.4M
High price	$50.31
Low price	$48.94
Monthly RSI	66.22
Open price	$49.45
Position in 52-week range	10.95%
Premarket change	1.38%
Premarket close	$47.85
Premarket price	$48.51
Premarket volume	4K
Previous close	$47.85
Price vs 150-day SMA	20.81%
Price vs 20-day SMA	8%
Price vs 200-day SMA	23.86%
Price vs 50-day SMA	11.59%
Relative volume	0.72
Return from IPO open	114.57%
Return from IPO price	135%
RSI	65.77
Sharpe ratio	1.81
Sortino ratio	5.23
Volume	578.7K
Weekly RSI	66.52
YTD price change	27.87%
YTD total return	27.87%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49.3M
Float percentage	31.11%
Shares change (QoQ)	-0.06%
Shares change (YoY)	-2.85%
Shares held by insiders	68.89%
Shares held by institutions	31.38%
Shares outstanding	158.3M
Short % of float	8.4%
Short % of shares	2.61%
Short ratio	5.3 days

Deeper analysis on PACS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PACS report

Is a complete PACS research report available?

No complete published report is available for PACS Group, Inc. (PACS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

PACS Group, Inc. (PACS)

Price

Financial snapshot

Fair-value bridge

Latest news · PACS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PACS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PACS

Frequently asked questions